Skip to main content

Quest Patient Service Centers will be closed on Thursday, November 26th and will close at 12:00 PM on Friday, November 27th in observance of Thanksgiving and to give our frontline team time to recharge. Don’t let the holiday interrupt your care. Plan your visit today.

Hide

Comment on ‘Predictive Factors for Eczematous Eruptions and Candidiasis During Anti-Interleukin-17 Treatment in Patients With Psoriasis’: Bimekizumab-Induced Spongiotic Dermatitis

Comment on ‘Predictive Factors for Eczematous Eruptions and Candidiasis During Anti-Interleukin-17 Treatment in Patients With Psoriasis’: Bimekizumab-Induced Spongiotic Dermatitis

Authors: Houff AN, Cohen J, Sami N

Citation: Clin Exp Dermatol. 2025 Nov 7:llaf425. doi: 10.1093/ced/llaf425. Online ahead of print.

Specialties: Dermatology, Immunology

Disclaimer: One or more of the authors of this publication were employed at the time by DermPath Diagnostics, a subsidiary of Quest Diagnostics.